Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - atenololum inn - filmuhúðuð tafla - 50 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - atenololum inn - filmuhúðuð tafla - 25 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - adrenalinum bítartrat (epinephrinum bítartrat) - stungulyf, lausn - 1 mg/ml

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - ephedrini chloridum - stungulyf, lausn - 50 mg/ml

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - naproxenum inn - magasýruþolin tafla - 250 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - naproxenum inn - magasýruþolin tafla - 500 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - tamoxifenum cítrat - tafla - 20 mg

Európai Unió - izlandi - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - augnlækningar - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Európai Unió - izlandi - EMA (European Medicines Agency)

mylan ireland limited - dímetýl fúmarat - heila-og mænusigg, köstum tilkynnt - Ónæmisbælandi lyf - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

lyfjaver ehf. - pregabalinum inn - hart hylki - 150 mg